CHANDAN HEALTHCARE LIMITED
NNSE:CHANDAN229.00
INR
0.00
(0.00%)
ISIN
INE0B2N01016
Return %
Stock
S&P 500
1Y
-29.10
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Lucknow India
- IPO Date
- Feb 17, 2025
- Website
- chandandiagnostic.com
- Similar Companies
- Business
- Chandan Healthcare Limited is an India-based integrated healthcare services provider specializing in diagnostic pathology, clinical radiology, and retail pharmacy operations. Founded in 2003 and headquartered in Lucknow, Uttar Pradesh, the company operates an extensive hub-and-spoke healthcare delivery and diagnostic network across Northern India, primarily serving markets in Uttar Pradesh and Uttarakhand. The company provides a comprehensive spectrum of clinical testing and healthcare retail services organized across two core operating divisions: Diagnostic Services and Retail Pharmacy. Its Diagnostic Services division offers a testing menu of over 1,400 investigations, comprising pathology testing, including clinical biochemistry, hematology, immunology, serology, microbiology, histopathology, cytopathology, and molecular diagnostics; and radiology and clinical imaging services, including magnetic resonance imaging (MRI), computed tomography (CT) scans, digital radiography (X-ray), 3D and 4D ultrasonography, Doppler studies, mammography, bone mineral densitometry (BMD), echocardiography, and electrocardiography (ECG). The diagnostic infrastructure consists of central reference laboratories, regional diagnostic centers, satellite laboratories, and a network of more than 300 patient collection centers, with key facilities accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). Through its subsidiary, Chandan Pharmacy Limited, the company operates a chain of retail pharmacy stores that dispense prescription pharmaceuticals; generic medicines; surgical disposables; medical devices; over-the-counter (OTC) healthcare products; and consumer wellness goods. In recent corporate developments, Chandan Healthcare Limited completed its Initial Public Offering (IPO) and listed its shares on the National Stock Exchange of India (NSE Emerge platform under ticker CHANDAN) in February 2025, raising approximately INR 107.27 crore to accelerate strategic growth initiatives. The company is utilizing the proceeds to expand its regional footprint through the establishment of new diagnostic reference laboratories and centers in locations such as Lucknow and Ayodhya, invest in advanced automated diagnostic and imaging equipment, expand its integrated retail pharmacy network, and scale digital health offerings including at-home sample collection services and digital report dispatch platforms.